- Home
- PSTL vs HRTX Comparison
PSTL vs HRTX Comparison
Compare PSTL & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTL
- HRTX
- Stock Information
- Founded
- PSTL 2018
- HRTX 1983
- Country
- PSTL United States
- HRTX United States
- Employees
- PSTL N/A
- HRTX N/A
- Industry
- PSTL Real Estate Investment Trusts
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- PSTL Real Estate
- HRTX Health Care
- Exchange
- PSTL Nasdaq
- HRTX Nasdaq
- Market Cap
- PSTL 335.6M
- HRTX 270.7M
- IPO Year
- PSTL 2019
- HRTX 1987
- Fundamental
- Price
- PSTL $14.32
- HRTX $2.11
- Analyst Decision
- PSTL Strong Buy
- HRTX Strong Buy
- Analyst Count
- PSTL 1
- HRTX 3
- Target Price
- PSTL $15.50
- HRTX $5.67
- AVG Volume (30 Days)
- PSTL 179.8K
- HRTX 1.6M
- Earning Date
- PSTL 05-06-2025
- HRTX 05-06-2025
- Dividend Yield
- PSTL 6.79%
- HRTX N/A
- EPS Growth
- PSTL 83.16
- HRTX N/A
- EPS
- PSTL 0.21
- HRTX N/A
- Revenue
- PSTL $76,372,000.00
- HRTX $144,285,000.00
- Revenue This Year
- PSTL $13.87
- HRTX $11.81
- Revenue Next Year
- PSTL $10.76
- HRTX $15.79
- P/E Ratio
- PSTL $67.06
- HRTX N/A
- Revenue Growth
- PSTL 19.87
- HRTX 13.57
- 52 Week Low
- PSTL $12.26
- HRTX $1.04
- 52 Week High
- PSTL $15.15
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- PSTL 60.91
- HRTX 44.61
- Support Level
- PSTL $13.95
- HRTX $2.32
- Resistance Level
- PSTL $14.23
- HRTX $2.46
- Average True Range (ATR)
- PSTL 0.25
- HRTX 0.14
- MACD
- PSTL -0.02
- HRTX -0.05
- Stochastic Oscillator
- PSTL 87.20
- HRTX 2.17
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.